RECRUITING

Eye Pressure Lowering Surgery

Talk to us

Conditions

GlaucomaIOPTrabeculectomy

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to determine if lowering the pressure inside the eye improves blood flow to the eye.

Official Title

Observational Study of Ocular Blood Flow Pre- and Post- Glaucoma Surgery Using Functional and Structural Optical Coherence Tomography

Quick Facts

Study Start:2014-02-01
Study Completion:2026-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT01931904

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 85 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Subjects diagnosed with perimetric open angle glaucoma or chronic angle closure glaucoma.
  2. * Subjects scheduled to undergo trabeculectomy or tube shunt surgery
  1. * Best-corrected visual acuity less than 20/40
  2. * Age \< 18 or \>85 years
  3. * Refractive error of \> +3.00 D or \< -7.00 D
  4. * Previous vision correction surgery such as Laser-Assisted in situ Keratomileusis (LASIK) or Photorefractive Keratectomy (PRK)
  5. * Previous intraocular surgery except for uncomplicated cataract extraction with posterior chamber intraocular lens implantation
  6. * Diabetic retinopathy
  7. * History of heart failure, myocardial infarction, transient ischemic attack or stroke
  8. * Other diseases that may cause VF loss or optic disc abnormalities
  9. * Inability to clinically view or photograph the optic discs due to media opacity or poorly dilating pupil
  10. * Inability to perform reliably on automated VF testing
  11. * Life-threatening or debilitating illness making it unlikely patient will successfully complete the study.
  12. * Refusal of informed consent or of commitment to the full length of the study

Contacts and Locations

Study Contact

Chinmay Deshpande, M.Optom.
CONTACT
503-494-9628
deshpanc@ohsu.edu
Denny Romfh, OD
CONTACT
503-494-4351
romfhd@ohsu.edu

Principal Investigator

Aiyin Chen, MD
PRINCIPAL_INVESTIGATOR
Oregon Health and Science University

Study Locations (Sites)

OHSU
Portland, Oregon, 97239
United States

Collaborators and Investigators

Sponsor: Oregon Health and Science University

  • Aiyin Chen, MD, PRINCIPAL_INVESTIGATOR, Oregon Health and Science University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2014-02-01
Study Completion Date2026-05

Study Record Updates

Study Start Date2014-02-01
Study Completion Date2026-05

Terms related to this study

Keywords Provided by Researchers

  • IOP
  • Glaucoma
  • Trabeculectomy

Additional Relevant MeSH Terms

  • Glaucoma